Henry Schein | HSIC - Equity Capital And Reserves


Henry Schein reported $3.27B in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Agilent USD 7.12B 214M Mar/2026
Align Technology USD 4.15B 100.27M Mar/2026
Bruker USD 2.46B 35.9M Dec/2025
Cardinal Health USD -2.83B 52M Mar/2026
Charles River Laboratories USD 2.9B 265.94M Mar/2026
Cigna USD 42.21B 497M Mar/2026
Concord Medical Services Hldg CNY -2.24B 362.55M Jun/2025
Cooper Companies USD 8.36B 124.7M Dec/2025
CVS Health USD 77.46B 2.24B Mar/2026
Danaher USD 52.95B 415M Mar/2026
Dentsply International USD 1.32B 21M Mar/2026
Encompass Health USD 2.52B 83.5M Mar/2026
Henry Schein USD 3.27B 21M Mar/2026
Idexx Laboratories USD 1.56B 49.28M Mar/2026
IQVIA Holdings USD 6.22B 282M Mar/2026
Laboratory Of America USD 8.73B 108.8M Mar/2026
McKesson USD -2.17B 874M Mar/2026
Mettler Toledo International USD -41.88M 18.25M Mar/2026
Owens Minor USD -464.76M 3.79M Mar/2026
Quest Diagnostics USD 7.37B 196M Mar/2026
Revvity USD 7.25B 125.54M Dec/2025
Stryker USD 22.42B 635M Dec/2025
Tenet Healthcare USD 4.81B 594M Mar/2026
Thermo Fisher Scientific USD 51.93B 1.6B Mar/2026
Universal Health Services USD 7.46B 189.06M Mar/2026
Veradigm USD 1.02B 159.52M Dec/2022
Waters USD 2.56B 230.55M Dec/2025
Zimmer Biomet Holdings USD 12.68B 16.1M Mar/2026
Zoetis USD 3.23B 98M Mar/2026